Levels of PRL, and by extension, lactogenic signaling via the PRLR, are not consistently associated with the risk of cardiovascular events, even though excess prolactin elevates the risk of endothelial dysfunction and metabolic disorders [14]. The gene discussed is PRLR; the disease is Other metabolic disease.